Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - TOTAL EQUITY
Total Equity ALNY - Alnylam Pharmaceuticals, Inc.
-221 M
LAST VALUE
-17.27%
2 YEAR CAGR
-3.18%
5 YEAR CAGR
-6.15%
10 YEAR CAGR